A Personalized, Medical Approach to Weight Management

 

Weight loss is not one-size-fits-all. MQ Institute uses a personalized, medically supervised approach based on each patient's health, lifestyle, medical history and goals. When medically appropriate, treatment may include GLP-1-based medications such as semaglutide or tirzepatide, plus monitoring, nutrition guidance and lifestyle support.

 

​request a consultation

 

 

 

A Weight Loss Plan Designed Around You

 

Care begins with an individualized medical evaluation. Program elements may include:

 

• Comprehensive medical evaluation and personalized plan
  
  
• GLP-1 treatment, semaglutide or tirzepatide when medically appropriate
  
  
• Laboratory testing when indicated
  
  
• Nutrition and lifestyle guidance
  
  
• Progress monitoring, medication management and ongoing medical support

 

 

 

GLP-1 Weight Management

 

GLP-1-based medications act on pathways involved in appetite, satiety, digestion, insulin response and blood glucose regulation. Position medication as one part of a comprehensive medically supervised plan - not a stand-alone solution.

 

 

 

Semaglutide

 

Semaglutide is a GLP-1 receptor agonist. Potential benefits for appropriate patients may include reduced hunger, increased fullness, support for portion control, blood glucose regulation and clinically meaningful weight loss.  BOOK A VISIT TO ASK IF SEMAGLUTIDE IS RIGHT FOR YOU.

 

 

 

Tirzepatide

 

Tirzepatide acts on GIP and GLP-1 receptors. Potential benefits for appropriate patients may include reduced appetite, increased fullness, support for blood glucose regulation and insulin sensitivity, and clinically meaningful weight reduction. ASK ABOUT TIRZEPATIDE.

 

 

 

More Than a Prescription

 

MQ Institute offers medical oversight, individualized nutrition/lifestyle recommendations, progress monitoring and ongoing support. Treatment can be adjusted as the patient's health, response and goals change.

 

 

 

Who Is a Candidate?

 

Candidacy depends on medical history, BMI, current medications, weight-related conditions, previous weight-management efforts, goals and contraindications. Consultation is required.  BOOK NOW.

 

MQ Institute provides medical weight management from its Severna Park location, serving patients throughout the greater Annapolis and Baltimore areas. Personalized medical weight management for eligible patients in Naples and surrounding Southwest Florida communities. Eligible patients in Maryland, Florida and California, including the La Jolla/San Diego area, subject to provider licensure, medical appropriateness and applicable requirements.

 

 

 

Possible Side Effects & Important Safety Information

 

Prescription weight-management medications can cause side effects and are not appropriate for everyone. Depending on the medication, common adverse reactions may include nausea, diarrhea, vomiting, constipation, abdominal pain/discomfort, indigestion, reflux, burping, fatigue, injection-site reactions and other gastrointestinal symptoms. Medication-specific reactions can differ.

 

Important risks and warnings may include pancreatitis, gallbladder disease, kidney injury related to dehydration/volume depletion, severe gastrointestinal reactions, serious allergic reactions, low blood sugar (especially with certain diabetes medications), delayed stomach emptying and potential aspiration risk during general anesthesia or deep sedation. Additional medication-specific risks and precautions may apply.

 

FDA-approved semaglutide and tirzepatide products used for chronic weight management carry boxed warnings concerning thyroid C-cell tumors observed in animals. It is unknown whether these medications cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. They are contraindicated in patients with a personal or family history of MTC or MEN 2.

 

Tirzepatide may affect absorption of oral medications and has specific contraceptive considerations. Patients should provide a complete medical history and medication/supplement list before treatment.

 

 

 

Individual Results Vary

 

Individual results vary. No specific amount, rate or duration of weight loss is promised or guaranteed.

 

Outcomes depend on factors including medical history, treatment selection, adherence, nutrition, physical activity, lifestyle and individual response. Testimonials, photos and individual experiences should not be interpreted as a guarantee of the same or similar results. Prescription medication is provided only when medically appropriate.

​

 

 

Frequently Asked Questions About Medical Weight Loss

 

How does medical weight loss work?

Medical weight loss at MQ Institute takes a comprehensive, physician-directed approach to achieving and maintaining a healthier weight. Treatment begins with an individualized assessment of medical history, metabolic health, lifestyle factors, and weight management goals. Laboratory testing and additional medical evaluations may be recommended when clinically indicated. Personalized treatment plans may incorporate nutritional guidance, physical activity, behavioral modifications, and prescription medications when appropriate. The focus extends beyond weight reduction to improving overall health and long-term wellness.

 

What are GLP-1 medications?

GLP-1 receptor agonists are medications that mimic a naturally occurring hormone involved in appetite regulation, blood sugar control, and feelings of fullness. These medications can help reduce hunger, increase satiety, and support weight management when combined with appropriate lifestyle modifications. Treatment requires medical evaluation and ongoing supervision.

 

What is the difference between semaglutide and tirzepatide?

Semaglutide acts on GLP-1 receptors to help regulate appetite, food intake, and blood sugar. Tirzepatide acts on both GLP-1 and GIP receptors, two hormone pathways involved in metabolic regulation. Both have demonstrated significant weight reduction in clinical studies, with tirzepatide producing greater average weight loss in certain comparative trials. The appropriate medication depends on individual medical history, treatment goals, contraindications, tolerability, and clinical assessment.

 

How much weight will I lose?

Weight loss varies based on individual metabolism, medical history, medication selection, lifestyle changes, and adherence to treatment. Although clinical studies demonstrate meaningful average weight reduction with certain medications, individual outcomes vary and cannot be guaranteed. At MQ Institute, the emphasis is on sustainable weight management, metabolic health, and overall well-being rather than achieving a specific number on the scale.

 

How quickly will I see results?

Some patients notice changes in appetite and weight during the first several weeks of treatment. More substantial results generally develop over several months as medication doses are gradually adjusted and healthy lifestyle habits are established. Response varies among individuals, and treatment progress is monitored to support safe, sustainable outcomes.

 

Are semaglutide and tirzepatide safe?

FDA-approved semaglutide and tirzepatide products have established safety and effectiveness profiles for appropriate patients when prescribed and monitored by qualified healthcare professionals. Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. More serious risks may include pancreatitis, gallbladder disease, dehydration-related kidney injury, and severe gastrointestinal reactions. These medications carry boxed warnings concerning thyroid C-cell tumors observed in rodents and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN2. A comprehensive medical assessment helps determine whether treatment is appropriate.

 

Do I still need nutrition and exercise changes?

Yes. Medication is one component of a comprehensive weight management program. Balanced nutrition, regular physical activity, adequate protein intake, resistance training, sleep optimization, and sustainable lifestyle habits remain essential. At MQ Institute, treatment emphasizes preserving lean muscle mass, supporting metabolic health, and developing habits that promote long-term success.

 

Do you offer telehealth for medical weight loss?

Yes. MQ Institute offers telehealth consultations for eligible patients in states where services are available. Virtual visits may include medical history review, weight management assessments, medication discussions, and ongoing treatment monitoring. Laboratory testing or in-person evaluation may be required when clinically indicated. Prescriptions are provided only when medically appropriate and in accordance with applicable state and federal regulations.

 

Do you serve Baltimore and Annapolis?

Yes. MQ Institute welcomes patients from Baltimore, Annapolis, Severna Park, and surrounding Maryland communities. Our Severna Park location offers individualized medical weight management consultations and treatment plans focused on overall health and sustainable results.

 

Do you offer medical weight loss in California?

Yes. MQ Institute currently offers telehealth consultations only in California for eligible patients. Services may include medical weight management assessments, personalized treatment recommendations, and ongoing follow-up when clinically appropriate. In-person services are not currently available in California.

 

 

 

Beyond Weight Loss. A Healthier, More Vibrant You.

At MQ Institute, medical weight management is about more than the number on the scale. Through comprehensive medical evaluations, personalized treatment, and ongoing physician-directed care, our goal is to optimize metabolic health, support sustainable weight management, and enhance overall wellness and longevity.

 

​request a consultation